Literature DB >> 7582109

Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity.

H Ushijima1, O Nishio, R Klöcking, S Perovic, W E Müller.   

Abstract

After incubation of highly enriched neurons from rat cerebral cortex with the HIV-1 coat protein gp120 for 18 h, cells showed fragmentation of DNA at internucleosomal linkers followed by NMDA receptor-mediated neurotoxicity. We report that in response to exposure to gp120 cells react with an increased release of arachidonic acid (AA) via activation of phospholipase A2. This process was not inhibited by NMDA receptor antagonists. To investigate the role of AA on the sensitivity of the NMDA receptor towards its agonist, low concentrations of NMDA were co-administered with AA. This condition enhanced the NMDA-mediated cytotoxicity. Administration of mepacrine reduced cytotoxicity caused by gp120. We conclude that gp120 causes an activation of phospholipase A2, resulting in the increased release of AA, which may in turn sensitize the NMDA receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582109     DOI: 10.1111/j.1460-9568.1995.tb01126.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  13 in total

1.  Human immunodeficiency virus type 1 clade B and C gp120 differentially induce neurotoxin arachidonic acid in human astrocytes: implications for neuroAIDS.

Authors:  Thangavel Samikkannu; Marisela Agudelo; Nimisha Gandhi; Pichili V B Reddy; Zainulabedin M Saiyed; Donald Nwankwo; Madhavan P N Nair
Journal:  J Neurovirol       Date:  2011-04-14       Impact factor: 2.643

2.  HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorder.

Authors:  Pichili Vijaya Bhaskar Reddy; Nimisha Gandhi; Thangavel Samikkannu; Zainulabedin Saiyed; Marisela Agudelo; Adriana Yndart; Pradnya Khatavkar; Madhavan P N Nair
Journal:  Neurochem Int       Date:  2011-07-03       Impact factor: 3.921

Review 3.  14-3-3s are potential biomarkers for HIV-related neurodegeneration.

Authors:  Diana Morales; Efthimios C M Skoulakis; Summer F Acevedo
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

4.  Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture.

Authors:  A Pérez; A W Probert; K K Wang; L Sharmeen
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

5.  Human immunodeficiency virus type 1 gp120 and ethanol coexposure in rat organotypic brain slice cultures: Curtailment of gp120-induced neurotoxicity and neurotoxic mediators by moderate but not high ethanol concentrations.

Authors:  A Belmadani; E J Neafsey; M A Collins
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

6.  gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1.

Authors:  O Meucci; R J Miller
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

7.  Soluble factors from IL-1β-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration.

Authors:  Tao Jing; Li Wu; Kathleen Borgmann; Sankar Surendran; Anuja Ghorpade; Jianuo Liu; Huangui Xiong
Journal:  Biochem Biophys Res Commun       Date:  2010-10-08       Impact factor: 3.575

8.  Binge ethanol-induced neurodegeneration in rat organotypic brain slice cultures: effects of PLA2 inhibitor mepacrine and docosahexaenoic acid (DHA).

Authors:  James Brown; Nicholas Achille; Edward J Neafsey; Michael A Collins
Journal:  Neurochem Res       Date:  2008-07-01       Impact factor: 3.996

9.  YWHAE/14-3-3ε: a potential novel genetic risk factor and CSF biomarker for HIV neurocognitive impairment.

Authors:  Diana Morales; Rosa Hechavarria; Valerie Wojna; Summer F Acevedo
Journal:  J Neurovirol       Date:  2013-08-27       Impact factor: 2.643

10.  M- and T-tropic HIVs promote apoptosis in rat neurons.

Authors:  Alessia Bachis; Francesca Biggio; Eugene O Major; Italo Mocchetti
Journal:  J Neuroimmune Pharmacol       Date:  2008-11-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.